The National Institute on Drug Abuse (NIDA) has unveiled a new scientifically validated online screening tool that can help providers uncover patients' problem substance use. The Tobacco, Alcohol, ...

Although most clinicians caring for youths aged 17 years or younger reported screening for substance use disorders, many did not do so at every checkup, and 36.9% did not use a standardized screening ...

A new two-item screening tool for illicit drug use was found to be as accurate, if not more accurate, than currently used primary care screening tools, as well as less time consuming, according to ...

As new ways to identify and treat people who use opioids and other drugs emerge, an independent panel of experts is recommending that health care providers screen their adult patients for illicit drug ...

Substance use disorders (SUDs) in oncology populations represent a significant yet underrecognized challenge, with prior research suggesting that up to 27 percent of cancer patients meet criteria for ...

These experiments demonstrate that powerful instinctive survival behaviors can be overcome by activating the brain’s reward pathway through the release of dopamine. Since rats do not have ...

Despite advances in technology and availability, one of the best ways for parents and health care providers to prevent or help stop adolescent substance use is still an old-fashioned conversation, ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Somewhere in the flurry of tests and questions at an annual primary ...

Alcohol, tobacco and substance use are common among young adults; problematic alcohol use is especially prevalent on college campuses. There are a variety of factors that influence individual patterns ...

In an effort to support students and help them succeed at CU, CAPS is committed to working with students to avoid pitfalls related to substance use. CAPS offers several services to address these ...

Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials Subscription-based tools (ie, PEPID, Micromedex, Lexicomp, Facts & ...